Evidence map›Paper›PMID 28747367›Full record

ArticleJournal of clinical microbiology2017

Rapid Detection of Bacillus anthracis Bloodstream Infections by Use of a Novel Assay in the GeneXpert System.

Padmapriya P Banada, Srinidhi Deshpande, Riccardo Russo, Eric Singleton, Darshini Shah, Bhavana Patel, Michele Burday, Ranie Koshy, Qing Wang, Martin Jones and 6 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. A simple and sensitive test forJournal of clinical microbiology · 2024
    Article
  2. The Biosafety Research Road Map: The Search for Evidence to Support Practices in the Laboratory-Applied biosafety : journal of the American Biological Safety Association · 2023
    Review
  3. Article
  4. Review of anthrax: A disease of farm animals.Journal of advanced veterinary and animal research · 2022
    Review
  5. Biodefence research two decades on: worth the investment?The Lancet. Infectious diseases · 2021
    Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Padmapriya P BanadaCenter for Emerging Pathogens, Division of Infectious Diseases, New Jersey Medical School, Rutgers Biomedical and Health Sciences University, Newark, New Jersey, USA.ORCID 0000-0002-5217-6142
Srinidhi DeshpandeCenter for Emerging Pathogens, Division of Infectious Diseases, New Jersey Medical School, Rutgers Biomedical and Health Sciences University, Newark, New Jersey, USA.
Riccardo RussoCenter for Emerging Pathogens, Division of Infectious Diseases, New Jersey Medical School, Rutgers Biomedical and Health Sciences University, Newark, New Jersey, USA.
Eric SingletonCenter for Emerging Pathogens, Division of Infectious Diseases, New Jersey Medical School, Rutgers Biomedical and Health Sciences University, Newark, New Jersey, USA.
Darshini ShahDepartment of Pathology and Laboratory Medicine, University Hospital, Newark, New Jersey, USA.
Bhavana PatelDepartment of Pathology and Laboratory Medicine, University Hospital, Newark, New Jersey, USA.
Michele BurdayDepartment of Pathology and Laboratory Medicine, University Hospital, Newark, New Jersey, USA.
Ranie KoshyBlood Bank/Transfusion Service, University Hospital, Newark, New Jersey, USA.
Qing WangDepartment of Pathology and Laboratory Medicine, University Hospital, Newark, New Jersey, USA.
Martin JonesCepheid, Sunnyvale, California, USA.
Alexander GallCepheid, Bothell, Washington, USA.
Sergey LokhovCepheid, Bothell, Washington, USA.
Robert KwiatkowskiCepheid, Sunnyvale, California, USA.
David PersingCepheid, Sunnyvale, California, USA.
Nancy ConnellCenter for Emerging Pathogens, Division of Infectious Diseases, New Jersey Medical School, Rutgers Biomedical and Health Sciences University, Newark, New Jersey, USA.
David AllandCenter for Emerging Pathogens, Division of Infectious Diseases, New Jersey Medical School, Rutgers Biomedical and Health Sciences University, Newark, New Jersey, USA allandda@njms.rutgers.edu.
Rutgers, The State University of New Jersey · USUniversity Hospital, Newark · US

Funding

Supplement request for Ebola diagnostic assay developmentR01AI098713 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI ALLAND, DAVID · 2012 to 2016
$6.1M
NIAID NIH HHS R01 AI098713
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Point-of-Care TestingAnthraxBacillus anthracisBacteremiaDNA, BacterialExpert SystemsGenome, BacterialHumansLimit of DetectionDNA, BacterialBacillus anthracisdiagnosticdiagnosticsGeneXpertwhole blood

Identifiers

PMID28747367
PMCPMC5625382
OpenAlexW2736871176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.